Decisions on adjuvant chemotherapy for patients with breast cancer based on clinical and evolving Oncotype DX criteria.

Jamal Zekri,Meteb Owaish Al-Foheidi,Maaz Kamal Alata,Ayman Rasmy,Haleem J. Rasool,Hossam Abdelrahman,Adnan Hussain,Yasser Sorour,Miral Mashhour

Decisions on adjuvant chemotherapy for patients with breast cancer based on clinical and evolving Oncotype DX criteria.

2019

Jamal Zekri
Meteb Owaish Al-Foheidi
Maaz Kamal Alata
Ayman Rasmy
Haleem J. Rasool
Hossam Abdelrahman
Adnan Hussain
Yasser Sorour
Miral Mashhour

e12009Background: Oncotype-DX assay recurrence score (ODX-RS) cut-off values have recently changed in response to the results of the TAILOR-X trial. We aim to explore decisions for ACT based on phy...

Keywords:

Breast cancer
Oncology
Adjuvant
Physical therapy
Oncotype DX
Chemotherapy
Medicine
Internal medicine
recurrence score
adjuvant chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations